Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) shares shot up 2.8% during mid-day trading on Wednesday . The ...
Hosted on MSN20h
Needham Upgrades Collegium Pharmaceutical (COLL)Fintel reports that on January 10, 2025, Needham upgraded their outlook for Collegium Pharmaceutical (NasdaqGS:COLL) from ...
Needham analyst upgrades Collegium Pharmaceutical to Buy with a $46 target, citing strong 2025 guidance, growth potential, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback